Filter Results:
(132)
Show Results For
- All HBS Web
(579)
- People (4)
- News (132)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(579)
- People (4)
- News (132)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Page 1 of 132
Results →
Sort by
- 27 Sep 2015
- News
Pharma gives drug development the Hollywood treatment
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
echoed Hamburg’s call for improvements in regulation, but he also emphasized the innovation side of the balancing act between safety and product development. “Reinvent invention,” he told the audience. The industry must get smarter about View Details
- 01 Mar 2004
- News
Drug Imports a Hot Topic at Alumni Health-Care Conference
between the high cost of developing prescription drugs and patient demand for lower prices. Speaking on “The Politics of Innovation,” McClellan acknowledged that many patients have resorted to buying View Details
- 04 Sep 2014
- News
Our focus was to get drug companies to invest money in ALS
millions of dollars into research, and removed critical barriers to the development of treatments. “Our focus was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed in 2004, just... View Details
- 01 Mar 2007
- News
Daniel Vasella
important to the defense side as to the attacking side. Novartis has 138 drugs in its pipeline, more than any of its competitors. How has the company become so successful at creating a culture of innovation? Initially, we spent a lot of... View Details
- 06 Mar 2020
- News
How Medical Nonprofits Set Winning Strategy
- 15 Mar 2019
- News
Targeting cancer and careers: Precision Medicine
- 30 Sep 2020
- News
How Nonprofit Foundations Can Sustainably Fund Disease Research
- 30 Dec 2010
- News
Shrink It, Cure It
- 27 Jun 2019
- News
Long-Term Investing, Short-Term Thinking
- 01 Dec 2023
- News
Wide Horizon
There were three critical events that led John Rodakis (MBA 1997) to form the nonprofit N of One in 2014 and ultimately dedicate his life to surfacing breakthrough autism research. The first occurred on Thanksgiving of 2012. He had driven about four hours with his wife... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 07 Feb 2024
- News
The Sound of Success
A groundbreaking gene therapy developed by Akouos, Inc., a precision genetic medicine company founded in 2016 by Emmanuel (Manny) Simons (MBA 2012), has enabled an 11-year-old boy from Morocco to hear sounds for the first time. According to a recent New York Times... View Details
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 01 Sep 2023
- News
Solving for Z
With nearly 20 years of experience as a senior human resources executive, Matthew Breitfelder (MBA 2002) has seen a lot of change in the corporate talent space. But what’s happening now looks like a tectonic generational shift. From his perch as global head of human... View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
On March 16, doctors at the Massachusetts General Hospital made history when they successfully transplanted a kidney from a genetically modified pig to a living human. The groundbreaking procedure marked a significant milestone in animal-to-human transplant, or... View Details
Keywords: Margie Kelley
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
for the development and exclusive use of the mRNA technology to treat cardiovascular, renal, and metabolic diseases as well as cancer. "It is one of the largest-ever initial payments in a pharmaceutical industry licensing deal that does... View Details